Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Chemomab Therapeutics Ltd.

CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534248

In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.

Holders of 5% or more of CMMB

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Chemomab Therapeutics Ltd., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CMMB
HolderLatest formStakeChangeFirst filedLatest filingFiling
HBM Healthcare Investments (Cayman) Ltd.13D/A12.50%81.0M shares0.00 ppfrom 12.50%Jul 16, 20262 filingsSep 9, 2026SEC
Scipher Medicine Corp13D10.40%74.6M sharesNewNov 10, 20261 filingNov 10, 2026SEC
Touchstone Global Investments Pty Ltd13G5.20%377.8K sharesNewAug 13, 20261 filingAug 13, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

25 Schedule 13D and 13G filings on Chemomab Therapeutics Ltd., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CMMB
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 10, 20265:30 PM ETScipher Medicine Corp13D10.40%74.6M sharesNewNov 3, 2026SEC
Sep 9, 20264:00 PM ETHBM Healthcare Investments (Cayman) Ltd.13D/A12.50%81.0M shares0.00 ppfrom 12.50%Sep 7, 2026SEC
Aug 13, 20268:38 AM ETTouchstone Global Investments Pty Ltd13G5.20%377.8K sharesNewAug 7, 2026SEC
Aug 10, 202611:58 AM ETOtto Erik13G/A1.20%90.0K shares−5.10 ppfrom 6.30%Below 5%Aug 10, 2026SEC
Jul 16, 20264:05 PM ETHBM Healthcare Investments (Cayman) Ltd.13D12.50%81.0M sharesNewJul 9, 2026SEC
Feb 17, 20264:48 PM ETThiel Peterand 1 other13G/A4.60%22.6M shares–Below 5%Dec 31, 2025SEC
Feb 10, 20264:43 PM ETOtto Erik13G/A6.30%385.0K shares−1.80 ppfrom 8.10%Feb 10, 2026SEC
Aug 11, 20251:04 PM ETOtto Erik13G/A8.10%1.69M shares–Aug 11, 2025SEC
Aug 7, 20254:21 PM ETMorgan Stanleyand 1 other13G/A3.20%13.2M shares−5.20 ppfrom 8.40%Below 5%Jul 31, 2025SEC
Aug 7, 202511:45 AM ETMorgan Stanleyand 1 other13G8.40%32.3M sharesNewJun 30, 2025SEC
Jun 23, 20255:06 PM ETOrbiMed Israel BioFund GP Limited Partnershipand 3 others13D/A4.80%969.8K shares–Below 5%Jun 18, 2025SEC
Apr 10, 20255:25 PM ETSphera Funds Management Ltd.and 2 others13G/A4.78%900.4K shares–Below 5%Mar 31, 2025SEC
Nov 29, 2024Mor George Adi13D/AOld format–––SEC
Nov 21, 2024Otto Erik13GOld format–New–SEC
Sep 16, 2024OrbiMed Israel BioFund GP Limited Partnership13D/AOld format–––SEC
Aug 20, 2024Sphera Funds Management Ltd.13GOld format–New–SEC
Mar 11, 2024OrbiMed Israel BioFund GP Limited Partnership13D/AOld format–––SEC
Nov 15, 2023OrbiMed Israel BioFund GP Limited Partnership13D/AOld format–––SEC
Jan 5, 2023OrbiMed Israel BioFund GP Limited Partnership13D/AOld format–––SEC
Nov 17, 2022Mor George Adi13D/AOld format–––SEC
Feb 10, 2022Gabriel Capital Management Ltd.13G/AOld format–––SEC
Jan 20, 2022Mor George Adi13DOld format–New–SEC
Apr 15, 2021Access Industries Holdings LLC13D/AOld format–––SEC
Mar 26, 2021Thiel Peter13GOld format–New–SEC
Mar 26, 2021OrbiMed Israel BioFund GP Limited Partnership13DOld format–New–SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell Chemomab Therapeutics Ltd. shares, newest first.

Form 144 notices for CMMB
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 12, 20244:56 PM ETOrbiMed Israel Partners Limited PartnershipOwner500.0K$1.01MSep 12, 2024Morgan StanleySEC